All studies
AuthorisedHuman Pharmacology (Phase I)- First administration to humansInterventional

A clinical trial of MK-1568 in participants with prostate cancer (MK-1568-001)

This clinical trial is studying a new medicine called MK-1568 for adult men with prostate cancer. It is a Phase 1 trial, which means it is the very first time this treatment is being tested in humans. The main aim of an early study like this is not yet to prove how well the medicine cures cancer, but to make sure it is safe. Researchers want to find out what side effects it might cause, how the body breaks it down, and what dose is safest to use in future trials. Joining the trial is completely voluntary. If you take part, doctors will monitor your health very closely with regular hospital visits, blood tests, and scans. Because this is a new drug, there is no guarantee it will improve your cancer, but it may help scientists develop new treatments for other men in the future.

At a glance

Status
Authorised
Phase
Human Pharmacology (Phase I)- First administration to humans
Sponsor
Merck Sharp & Dohme LLC
Enrolment target
15
Start
03 Nov 2026

What is this study about?

Prostate cancer is the most common cancer in men in the UK. While there are several effective treatments available, doctors are always searching for newer and better options, especially for when standard therapies stop working. This trial is investigating a brand-new experimental drug called MK-1568 to see if it could become a future treatment option.

This is a Phase 1 clinical trial, often referred to as a 'first-in-human' study. Before a drug reaches this stage, it has only been tested in laboratory experiments. The primary goal of a first-in-human study is to understand safety. Researchers need to see how the human body tolerates the drug, identify any unexpected side effects, and determine how much of the medicine can be given safely without causing too much discomfort.

During the trial, doctors start by giving very small doses of MK-1568 to a small group of patients. If the medicine proves safe, slightly higher doses may be given to the next group. This careful, step-by-step process helps researchers pinpoint the best dose for larger studies later on.

Studies like this are vital because every approved cancer medicine used in the NHS today began in a Phase 1 trial. By taking part, volunteers help scientists take the very first step toward learning whether this new medicine has the potential to fight prostate cancer.

Key takeaways

  • This is an early-stage Phase 1 trial testing a new drug called MK-1568 for the first time in humans.
  • The primary aim is to check the medicine's safety, side effects, and correct dosage in men with prostate cancer.
  • Participation requires frequent hospital visits for blood tests, health checks, and monitoring.
  • There is no guaranteed health benefit, and side effects are not yet fully known.
  • Joining is completely voluntary, and you can withdraw at any time without losing your standard care.

Who may be eligible?

This study is designed specifically for adult men aged 18 and over who have been diagnosed with prostate cancer. Because this is a very early trial, doctors usually look for patients whose cancer may have returned or continued to grow despite having standard treatments.

To be eligible, you must be well enough to attend regular hospital appointments and manage daily activities. Your vital organs, such as your heart, liver, and kidneys, must also be working well enough to safely handle a new medicine.

You might not be able to join if you have certain other serious health conditions, active infections, or if you are currently taking other experimental treatments. Your cancer specialist will review your full medical history and perform tests to see if this study is suitable for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am male and at least 18 years old.
  2. I have been diagnosed with prostate cancer.
  3. I am well enough to travel to hospital for regular clinic visits.
  4. I am willing to undergo frequent health monitoring, including blood tests and scans.
  5. I am open to trying an experimental medicine that has not been tested in people before.
Answer every question to see your result.

What does participation involve?

Taking part in this trial involves visiting a specialist hospital clinic regularly. At the start, you will have a thorough screening visit, which includes blood tests, heart checks, and scans to confirm that the trial is safe for you. If you join, you will be given the study drug, MK-1568, which may be given as a tablet or through a drip into your vein. Because this is a safety study, you will have frequent check-ups, especially in the early weeks. Doctors will take regular blood samples to see how the medicine moves through your body and will monitor any symptoms you experience. You will also have periodic scans to check on your cancer. The total length of time you take part will depend on how your body handles the medicine and how your cancer responds, but follow-up checks will continue for several weeks or months after your last dose.

Potential risks and benefits

Because MK-1568 is being tested in humans for the first time, there are unknown risks and potential side effects that researchers cannot fully predict. Common side effects might include tiredness, sickness, or changes in your blood test results, but more serious reactions are also possible. There is no guarantee that the treatment will shrink your cancer or help you feel better personally. However, the information gathered will help doctors learn more about treating prostate cancer in the future. Throughout the study, your medical team will watch your health very closely. You are always in control, and you have the right to withdraw from the trial at any time without it affecting your normal NHS care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Netherlands

Common questions

What does a Phase 1 clinical trial mean?

A Phase 1 trial is the earliest stage of testing a new medicine in people. Its main goal is to find out if the drug is safe, what side effects it causes, and what dose works best.

Will this drug cure my prostate cancer?

It is not possible to say. Because this is the first time the drug is being given to humans, doctors do not yet know how well it works against cancer. You should not join expecting a cure.

Do I have to pay to take part?

No, you do not pay for the trial medication or trial-related tests. In many cases, help may also be available to cover your travel expenses to and from hospital visits.

Can I leave the study if I change my mind?

Yes. Taking part is completely voluntary. You can stop taking the medicine and leave the trial at any point, and your regular doctors will continue to look after you.

What happens if I get unpleasant side effects?

You will be given contact details for the trial team and should report any new symptoms straight away. The doctors can pause treatment, adjust the dose, or stop it completely to keep you safe.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.